Azeem Latib

Azeem Latib

Section Head of Interventional Cardiology

Montefiore Medical Center, New York, NY, US

  • LinkedIn
  • Twitter
  • Radcliffe
  • OrcidID


Personal History

Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology.1

In his free time, he loves the outdoors and being in nature with his family. He speaks English, Italian and Afrikaans.3, 4


Academic History

In 1995, Dr Latib obtained his M.D. from University of the Witwatersrand, Johannesburg and did his Residency in Cardiology at Groote Schuur Hospital, Cape Town, South Africa. He did his Internal Medicine Internship at the Groote Schuur Hospital and his Interventional Cardiology Fellowship at the San Raffaele Scientific Institute & University Vita Salute, Milan, Italy.1

He completed a fellowship with the College of Physicians of South Africa in 2002, followed by a certificate in cardiology from the same institution in 2005. In 2008, he completed a Master’s in Interventional Cardiology at San Raffaele Scientific Institute and University Vita Salute in Milan, Italy. In 2018 he attended the University of Zurich, where he earned a certificate of advanced studies in aortic structural interventions.1, 2


Career Overview

Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care. 

His focus is on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. His main clinical interests include Complex Coronary Interventions, Structural Heart Disease and New Device Innovation. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.1

Dr Latib is currently involved in the development of the NeoChord NeXuS Transcatheter Mitral Chordal Repair Device and procedure.5

Dr Latib has over 550 peer-reviewed journal articles to his name. He serves on the editorial board ofmany journals, including Cardiac Interventions Today, the Journal of the American College of Cardiology, Cardiovascular Interventions and Cardiovascular Revascularization Medicine. He is a reviewer for many more journals and serves on the faculty of several international conferences.2

Dr Latib is a member of several professional organizations, including the American College of Cardiology and the European Society of Cardiology.2


Career Timeline

  • 1997 - 2005: Medical Registrar and Cardiologist, Groote Schuur Hospital
  • 2009 - 2018: Interventional Cardiologist, EMO-GVM Centro Cuore Columbus
  • 2009 - 2018: Interventional Cardiologist, Università Vita-Salute San Raffaele Milano
  • Montefiore Health System
    • 2020 - Present: Section Head and Director of Interventional Cardiology
    • 2019 - Present: Medical Director of Structural Heart Interventions


Areas of Speciality

  • Interventional Cardiology



  • 2014: Winner of Young Leadership Recognition Award of the Cardiovascular Revascularization Therapy (CRT)
  • 2004: University of Cape Town Jackson Award for the Registrar who has made the best presentations at medical rounds
  • 2003: MM Suzman Medal for Outstanding Performance in Fellowship Examination of College of Physicians & Top Physician to qualify in South Africa in 2002
  • 2001: Oates Award for Outstanding Medical Registrar, Department of Medicine, Groote Schuur Hospital 




Dr Latib is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).

Articles by Azeem Latib, Section Head of Interventional Cardiology

Rediscovered and Unforgotten: Transcatheter Interventions for the Treatment of Severe Tricuspid Valve Regurgitation

Kusha Rahgozar, Sharon Bruoha, Edwin C Ho, et al


Citation: US Cardiology Review 2021;15:e22.

Transcatheter Mitral Valve Replacement: Current Evidence and Concepts

Ozan M Demir, Mhairi Bolland, Jonathan Curio, et al


Citation: Interventional Cardiology Review 2021;16:e07.

Rotational Atherectomy: A Contemporary Appraisal

Tanush Gupta, Michael Weinreich, Mark Greenberg, et al


Citation: Interventional Cardiology Review 2019;14(3):182–9.

Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment

Jonathan Curio, Ozan M Demir, Matteo Pagnesi, et al


Citation: Interventional Cardiology Review 2019;14(2):54–61.

Delayed Coronary Occlusion After Transcatheter Aortic Valve Implantation: Implications for New Transcatheter Heart Valve Design and Patient Management

Richard J Jabbour, Akihito Tanaka, Antonio Colombo, et al

Citation: Interventional Cardiology Review 2018;13(3):137–9.

Predilatation Prior to Transcatheter Aortic Valve Implantation: Is it Still a Prerequisite?

Matteo Pagnesi, Luca Baldetti, Paolo Del Sole, et al

Citation: Interventional Cardiology Review 2017;12(2):116–25.

Assessing the Risk of Leaflet Motion Abnormality Following Transcatheter Aortic Valve Implantation

Luca Testa, Azeem Latib,

Citation: Interventional Cardiology Review 2018;13(1):37–9.

How to Select the Most Appropriate Patient and Lesion to be Treated with a Coronary Bioresorbable Vascular Scaffold

Charis Costopoulos, Azeem Latib, Antonio Colombo, et al

Citation: Interventional Cardiology Review 2013;8(2):90-2